美国Synthetic Genomics
合成基因公司是一家致力于商业化基因组驱动技术。我们的科学的力量在于由创始人的开拓性研究数十年，奎格文特，博士，诺贝尔奖获得者汉密尔顿史密斯博士和他们所领导的科学小组组装。博士文特尔和他的球队已经证明了决策的科学突破的转化为商业上可行的解决方案纪录。

该公司的科研能力囊括诸如环境基因组学，微生物学，生物化学，生物信息学，植物基因组学，基因组工程，合成生物学领域和气候变化。除了强大的应用研究在国际创价学会进行的努力，公司赞助在J. Craig Venter研究所，基础研究一不以超过400名科学家和在基因组研究和政策方面的各种工作人员的非营利组织。除了知识产权内部开发，SGI公司独家获得新的发明和开发的JCVI赞助下，研究这两个组织之间的协定合成基因组研究的发现。

Synthetic Genomics Inc. was founded to commercialize genomic-driven technologies. Our scientific strength lies in the decades of pioneering research by founders, J. Craig Venter, Ph.D., Nobel Laureate Hamilton O. Smith, M.D., and the leading scientific teams they have assembled. Dr. Venter and his teams have proven track records of making scientific breakthroughs that translate into viable commercial solutions.

The company's scientific capabilities encompass areas such as environmental genomics, microbiology, biochemistry, bioinformatics, plant genomics, genome engineering, synthetic biology, and climate change. In addition to the strong applied research efforts conducted at SGI, the company sponsors fundamental research at the J. Craig Venter Institute, a not-for-profit organization with more than 400 scientists and staff working on a variety of genomic research and policy fronts. In addition to the Intellectual Property developed internally, SGI has exclusive access to new inventions and discoveries in synthetic genomics research developed by the JCVI under the Sponsored Research Agreement between both organizations.